Illumina unveils upgraded genome sequence service
The IGS service uses Illumina’s HiSeq 2500 sequencing system, which is capable of completing a sequencing run on a whole human genome in one day. The service, which
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired.
Pursuant to the agreement, screening and hit-to-lead chemistry will take place in the Broad’s Chemical Biology Platform and AstraZeneca will optimize, develop and commercialize potential compounds from identified,